Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 136

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 136
---
             | 10,123,771 |     | $ |  1,011 |     |        34 |     | $ | -      |     |    15,007 |     | $ |      2 |     |        | 5,258,235 |     | $ |    527 |     |           | 29,338 |     | $ |      3 |     | $ | 15,403,050 |   |     | $ | (204,847      | ) |     | $ | (20,417,118 | ) |     | $ | (5,217,372 | ) |

The Accompanying Notes are an Integral Part of These Financial Statements

All stock amounts have been retroactively adjusted to reflect a 1 for 1500 reverse stock split of all issued series of stock effective as of March 6, 2023

<div align='center'>103

REGEN BIOPHARMA , INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS</div>

| CASH FLOWS FROM OPERATING ACTIVITIES                                        |     | Years Ended September 30, 
 2024                      
 (As Restated)             |          |   |     | 2023 |            |   |
|:----------------------------------------------------------------------------|:----|:--------------------------|---------:|:--|:----|:-----|-----------:|:--|
| Net Income (loss)                                                           |     | $                         | (668,255 | ) |     | $    |  1,156,507 |   |
| Adjustments to reconcile net loss to net cash used in operating activities: |     |                           |          |   |     |      |            |   |
| Common Stock issued for Expenses                                            |     |                           |  145,500 |   |     |      |    250,000 |   |
| Preferred Stock issued as compensation                                      |     |                           |   13,048 |   |     |      |    348,372 |   |
| Common Stock issued for Compensation                                        |     |                           |   37,463 |   |     |      |          - |   |
| Interest expense attributable to amortization of Discount                   |     |                           |  (28,998 | ) |     |      |        864 |   |
| Derivative Expense                                                          |     |                           |    4,090 |   |     |      | (2,